title: [Acral erythema after allogeneic graft of the bone marrow].
abstract: Acral erythema (AE) is a painful, erythematous bullous eruption of the palms and soles which is chemotherapy-induced. To the numerous chemotherapies which induce AE we must add, perhaps, a new drug, Vépéside. AE is followed by graft-versus-host-disease in all patients receiving bone marrow transplantation. AE and early GVH disease being very similar, we discuss the differential diagnosis which can be very difficult.
authors.affiliation: Service de Dermatologie, CHRU, Caen.
authors.forename: F
authors.initials: F
authors.lastname: Dechaufour
authors.forename: A
authors.initials: A
authors.lastname: Dompmartin
authors.forename: X
authors.initials: X
authors.lastname: Troussard
authors.forename: F
authors.initials: F
authors.lastname: Galateau
authors.forename: S
authors.initials: S
authors.lastname: Pedailles
authors.forename: B
authors.initials: B
authors.lastname: Remond
authors.forename: M
authors.initials: M
authors.lastname: Leporrier
authors.forename: D
authors.initials: D
authors.lastname: Leroy
mesh_terms: D000169:Acrodermatitis / Q000209:etiology* / Q000473:pathology; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects; D004890:Erythema / Q000139:chemically induced* / Q000473:pathology; D005047:Etoposide / Q000009:adverse effects; D005260:Female; D006087:Graft vs Host Reaction; D006801:Humans; D008297:Male; D014184:Transplantation, Homologous
chemical_list: D000970:Antineoplastic Agents; D003561:Cytarabine; D005047:Etoposide
vernacular_title: Erythème acral après greffe de moelle osseuse allogénique.